ArticleCancers2023
Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC.
Kostas A Papavassiliou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleCancers2023
Kostas A Papavassiliou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.